Stocks and Investing Stocks and Investing
Tue, September 6, 2022
Mon, September 5, 2022
Fri, September 2, 2022
Thu, September 1, 2022
Wed, August 31, 2022
Tue, August 30, 2022
Mon, August 29, 2022

John Eade Upgraded (AZN) to Strong Buy and Held Target at $75 on, Aug 29th, 2022


Published on 2024-10-27 22:51:23 - WOPRAI
  Print publication without navigation


John Eade of Argus Research, Upgraded "AstraZeneca PLC" (AZN) to Strong Buy and Held Target at $75 on, Aug 29th, 2022.

John has made no other calls on AZN in the last 4 months.



There is 1 other peer that has a rating on AZN. Out of the 1 peers that are also analyzing AZN, 0 agree with John's Rating of Hold.



This is the rating of the analyst that currently disagrees with John


  • Andrew Berens of "SVB Leerink" Maintained at Buy with Increased Target to $75 on, Wednesday, May 4th, 2022